Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-10

Clinical Trial Update: Impact of Exogenous Ketones on Sleep Disruption in Vulnerable Populations [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update from Johns Hopkins evaluating whether exogenous ketone supplements affect sleep disruption in individuals with obstructive sleep…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exogenous ketone supplements (exogenous ketones)

Snippet

Sponsor: Johns Hopkins University | Conditions: Obstructive Sleep Apnea, Sleep | Phase 1 | Status: SUSPENDED